Skip to main content
. 2022 Dec 9;12(7):7724–7733. doi: 10.1002/cam4.5526

FIGURE 3.

FIGURE 3

Kaplan–Meier curves for subgroup analysis of PFS. (A) Age; (B) Sex; (C) ECOG PS; (D) Pathology; (E) PD‐L1 tumor proportion score (TPS); (F) Cycles of rh‐endostatin combined with camrelizumab and chemotherapy treatment; (G) Maintenance treatment.